- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00208429
A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip Replacement
Uncontrolled Prospective Multi-Centre Post Marketing Surveillance Study to Monitor the Long Term Survivorship of Pinnacle Acetabular Cup System With a Metal on Enduron Polyethylene Bearing in Subjects With Aetiologies Requiring a Primary Total Hip Replacement
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
i) Male or female subjects, aged between 18 and 70 years inclusive.
ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
iv) Subjects undergoing primary total hip replacement who are suitable for a cementless acetabular component and a metal on polyethylene bearing.
Exclusion Criteria:
i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
ii) Subjects undergoing revision hip replacement.
iii) Subjects undergoing simultaneous bilateral hip operation.
iv) Subjects with a contralateral hip replacement, which was implanted less than six months previously or is not performing satisfactorily.
v) Women who are pregnant.
vi) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
vii) Subjects who have participated in a clinical study with an investigational product in the last 12 months.
viii) Subjects who are currently involved in any injury litigation claims.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Pinnacle Acetabular System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Kaplan-Meier survivorship calculated at the five-year time-point.
Time Frame: 5 yrs post surgery
|
5 yrs post surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Baseline to post-operative assessment in clinical outcome using the Harris Hip Score
Time Frame: 6mths, 1yr, 2yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery
|
6mths, 1yr, 2yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery
|
|
Change in Baseline to post-operative assessment in clinical outcome using the Oxford Hip Score
Time Frame: Annually up to 15 yrs post-surgery
|
Annually up to 15 yrs post-surgery
|
|
Kaplan-Meier survivorship
Time Frame: Annually up to 15 yrs post-surgery
|
Annually up to 15 yrs post-surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Wounds and Injuries
- Leg Injuries
- Congenital Abnormalities
- Joint Diseases
- Musculoskeletal Diseases
- Connective Tissue Diseases
- Bone Diseases
- Hip Injuries
- Musculoskeletal Abnormalities
- Joint Dislocations
- Bone Diseases, Developmental
- Osteochondrodysplasias
- Epiphyses, Slipped
- Femoral Fractures
- Arthritis
- Necrosis
- Fractures, Bone
- Rheumatic Diseases
- Collagen Diseases
- Hip Dislocation
- Developmental Dysplasia of the Hip
- Hip Dislocation, Congenital
- Slipped Capital Femoral Epiphyses
Other Study ID Numbers
- CT03/40
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.